Aims: Deep brain stimulation of the subthalamic nucleus (STN-DBS) has become an effective treatment strategy for patients with Parkinson's disease. However, the biological mechanism underlying DBS treatment remains poorly understood.
| INTRODUCTION
Despite the significant therapeutic effects of STN-DBS, an important but unanswered question is how STN-DBS modulates brain activity, thereby leading to its therapeutic effects in PD. In the early 1990s, it was proposed that bradykinesia of PD was associated with an abnormal striato-thalamo-cortical (STC) pathway, in which hyperactivity in the STN and globus pallidus internus (GPi) enhanced striatal inhibition of the thalamo-cortex ensemble. 3, 4 According to the STC model, STN-DBS was initially thought to reduce activity in the target (ie, the STN), relieve striatal inhibition of the thalamocortex, and subsequently restore motor function in patients (the inhibition hypothesis). In contrast, the excitation hypothesis, in which DBS is thought to activate local neuronal elements in the stimulated site (eg, the STN), has also been proposed because increased output from the target during DBS was observed based on neural recording and neural transmitter studies. 5, 6 However, it was further observed that DBS may play a more complicated role than simple inhibition or excitation. The benefit of STN-DBS may be associated with the disruption of the pathologic beta-band oscillation and the information flow within the STC pathway (the disruption hypothesis). 
| METHODS

| Search criteria and data extraction
A literature search was conducted in PubMed (www.pubmed. 
| Meta-analysis based on activation likelihood estimation
The STN-DBS meta-analyses were conducted using GingerALE version 2.3.3 (http://brainmap.org/ale/). An ALE analysis represents a coordinate-based meta-analysis of neuroimaging studies, and this type of analysis treats the reported foci as an uncertainty distribution. 17 In the ALE, foci were modeled as a spatial 3D Gaussian probability distribution using various full-width-at-half-maximum (FWHM) values that were different from the sample sizes across the studies. Thus, for each study, we generated a modeled activation map by converting foci into a probability distribution. In the map, the value of every voxel represented the probability distribution of the peak coordinates obtained from the study. Next, the convergence of all the modeled activation maps across studies was used to obtain voxel-wise ALE scores by estimating the uncertain peaks, which reflect the union of the activation probabilities across experiments. Finally, the ALE score of each voxel was compared with the null hypothesis distribution through a permutation analysis (N = 5000). A multiple comparison correction was conducted with P < 0.001 (uncorrected) as a voxel-level threshold and a cluster-level threshold of P < 0.05. Importantly, prior to the meta-analysis, the peak foci reported in the MNI space were first transformed into the stereotactic Talairach atlas using the icbm2tal (Lancaster) transformation. 
| Processing of R-fMRI dataset and functional connectivity analysis
To further explore whether STN-DBS modulates functional brain activity in patients with PD on a network level, we performed a four- 
| RESULTS
| Studies included in the meta-analysis
The literature search and study selection process are shown in Figure 1 . The literature search yielded 13 functional imaging studies that reported STN-DBS effects on brain activities. A total of 147 PD patients were included. In the study of Cilia et al, 15 one of the reported coordinates in the thalamus showed inconsistent spatial location with the brain region described by the author. Therefore, we performed the meta-analysis with the foci excluding the inaccurately described coordinate. Given that tremor may have a potential influence on neuroimaging results, we also summarized the tremor information of the patients in the included studies (Table 1) .
| STN-DBS effect on brain activity in the resting state
The ALE meta-analysis revealed that STN-DBS elevated cerebral blood flow or metabolism in the left thalamus and STN (Figure 2A Tremor was not excluded.
Sestini et al. and Table 2 ) and decreased cerebral blood flow or metabolism in the bilateral caudal SMA, right GPi/thalamus, and left M1 area ( Figure 2B and Table 2 ).
| Functional connectivity analysis of R-fMRI dataset
An R-fMRI functional connectivity analysis in healthy subjects was performed to explore whether these clusters, identified by a metaanalysis of 13 studies, were densely connected with each other. The within-group results showed that each cluster had strong functional connectivity to the other regions (P < 10 −4
, Bonferroni corrected; Figure S1 ). Figure 3 shows that five clusters were strongly connected with each other within the same network.
| DISCUSSION
In our study, an ALE-based meta-analysis revealed that STN-DBS of patients with PD impacted five brain regions (decreased activity:
left SMA, right SMA, left M1 area, and the right thalamus; increased activity: left thalamus), which also constituted a tightly correlated STN-DBS effective network. We postulate that the STN-DBS effective network may underlie the neural modulation by STN-DBS treatment and provides clinical suggestions for treatment assessments. 
| Alterations of brain activity in cortical areas (caudal SMA and M1) in response to STN-DBS
| Alterations of brain activity in subcortical areas (thalamus) in response to STN-DBS
The meta-analysis of 13 studies revealed contradictory responses of the left and the right thalamus/STN/GPi areas to STN-DBS. These inconsistent alterations may be associated with several facts. First, lateralization effect was considered one of the factors. To date, some evidence has shown that unilateral DBS resulted in opposite brain activity changes in subcortical areas. 31 In our study, 11 studies involved bilateral STN-DBS stimulation, and the other two studies were confined to unilateral STN stimulation ( Table 1 
| Limitations
Several limitations also existed in our study. First, PD can be classi- . Collectively, these data lead us to postulate that the STN-DBS effective network, which is composed of the bilateral SMA and left M1 areas, and the bilateral thalamus/STN/GPi, may underlie the neural substrate of the therapeutic benefit of STN-DBS. CAU, caudate nucleus; DA, dopamine; GABA, gamma amino butyric acid; Glu, glutamate; GPe, globus pallidus externus; GPi, globus pallidus internus; PUT, putamen; SNc, substantia nigra pars compacta; STN, subthalamic nucleus; THA, thalamus
In summary, we conclude that STN-DBS decreases brain activity in the motor cortex via network modulation and affects brain activity in subcortical regions in patients with PD. These areas were also functionally connected within the STN-DBS effective network. These results shed new light on the potential biological mechanisms of STN-DBS treatment from a network perspective, highlighting the potential therapeutic benefits of targeted brain network modulation.
